Prurigo Nodularis Research Trial (48 weeks)

Adults aged 18 to 75 with a clinical diagnosis of prurigo nodularis (PN) for at least 3 months, may qualify to participate. Individuals must have 20 or more PN nodules (bumps) on 2 or more different body regions. Poor response or intolerance to ongoing or previous PN therapy, is also required. The level of pruritis (itch) will also be assessed.

Participants will receive investigational oral medication (active study drug) or placebo, in tablet form, during the placebo-controlled treatment period. During the extension period, all participants will receive active study drug. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last up to 48 weeks and involve 13 visits to the study centre.

Call the study centre near you, or register now

Learn more about
Prurigo Nodularis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more